In non-diabetic chronic nephropathies urinary protein excretion rate accurately predicts progression to end stage renal failure (ESRF).

被引：0
|
作者：
Ruggenenti, P
Perna, A
Lanzoni, M
Remuzzi, G
机构：
[1] MARIO NEGRI INST PHARMACOL RES,I-24100 BERGAMO,ITALY
[2] OSPED RIUNITI BERGAMO,I-24100 BERGAMO,ITALY
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A0390 / A0390
页数：1
相关论文
共 50 条
  • [1] Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies
    Ruggenenti, P
    Perna, A
    Mosconi, L
    Pisoni, R
    Remuzzi, G
    KIDNEY INTERNATIONAL, 1998, 53 (05) : 1209 - 1216
  • [2] Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies
    Ruggenenti, P
    Perna, A
    Mosconi, L
    Matalone, M
    Pisoni, R
    Gaspari, F
    Remuzzi, G
    KIDNEY INTERNATIONAL, 1997, : S54 - S57
  • [3] In non-diabetic chronic nephropathies, hypertension and proteinuria are the strongest predictors of GFR decline (Delta GFR) and progression to end stage renal failure (ESRF).
    Perna, A
    Remuzzi, G
    Ruggenenti, P
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0692 - A0692
  • [4] Spot morning urine protein to creatinine (P/C) ratio correlates with 24-hour proteinuria and predict rate of GFR decline (Delta GFR) and progression to end stage renal failure (ESRF) in non-diabetic chronic nephropathies.
    Matalone, M
    Gaspari, F
    Ruggenenti, P
    Perna, A
    Remuzzi, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0681 - A0681
  • [5] The angiotensin-converting-enzyme (ACE) inhibitor ramipril slows the rate of GFR decline (Delta GFR) and the progression to end stage renal failure (ESRF) in proteinuric, non-diabetic chronic renal diseases.
    Ruggenenti, P
    Perna, A
    Mosconi, L
    Matalone, M
    Gaspari, F
    Garini, G
    Salvadori, M
    Zoccali, C
    Scolari, F
    Maggiore, Q
    Tognoni, G
    Remuzzi, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0696 - A0696
  • [6] Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure
    Fouque, D
    Wang, P
    Laville, M
    Boissel, JP
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (12) : 1986 - 1992
  • [7] Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies
    Cinotti, GA
    Zucchelli, PC
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (05) : 961 - 966
  • [8] DIABETIC END STAGE RENAL-FAILURE (ESRF) - 11 YEARS EXPERIENCE
    THOMPSON, TJ
    KIDNEY INTERNATIONAL, 1986, 30 (04) : 629 - 629
  • [9] Chronic nephropathies: Individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic model
    Dimitrov, BD
    Ruggenenti, P
    Stefanov, R
    Perna, A
    Remuzzi, G
    NEPHRON CLINICAL PRACTICE, 2003, 95 (02): : C47 - C59
  • [10] ACE genotype in ADPKD 1: A marker for a faster progression to end stage renal failure (ESRF)?
    Oldrizzi, L
    Marcantoni, C
    Turco, AE
    Gammaro, L
    Pignatti, PF
    Maschio, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1743 - A1743
12345